The Precision Cellular Therapy Laboratory
Overview
The Precision Cellular Therapy Laboratory is dedicated to advancing the understanding and effectiveness and safety of cellular therapies. Our research primarily focuses on uncovering drivers and mechanisms of resistance and toxicity that challenge the success of cellular therapies such as chimeric antigen receptor T-cell therapy and hematopoietic cell transplantation. By integrating multiomic approaches and novel computational techniques, we strive to identify and decode the biological drivers of disease resistance and adverse outcomes. Our goal is to translate these insights into more precise and safer therapeutic strategies, ultimately enhancing patient outcomes in hematologic malignancies and beyond.
Current Projects:
- Synthesizing multimodal data for prediction of CAR-T cell therapy outcome
- Uncovering genomic drivers of resistance to CAR-T cell therapy in lymphoma
- Dynamic Modeling of Cellular Therapy Toxicity
Publications
2026
Tumor CD19 expression determines distinct clinical outcomes after CD19 CAR T-cell therapy in large B-cell lymphoma. Corona M, Gillmor A, Argyropoulos KV, Fei T, Sotelo-Alva MI, Alhomoud M, et al. Blood Cancer Discov. 2026 Aug 31. doi:10.1158/2643-3230.BCD-25-0501.
Outcomes of salvage therapy after early-line CD19 chimeric antigen receptor T-cell failure in large B-cell lymphoma. Escribano Serrat S, Ip A, Sanz J, Gomez-Llobell M, Einarsdottir S, Marcus R, et al. Transplant Cell Ther. 2026;32(8):950.e1-950.e16. doi:10.1016/j.jtct.2026.04.003.
Safety and outcomes of CD19 CAR-T cell therapy in splenectomized patients with B-cell lymphomas. Shibli N, Einarsdottir S, Fei T, Shouval R, Perales MA, Gomez-Llobell M, et al. Transplant Cell Ther. 2026 Jun 26:S2666-6367(26)00521-X. doi:10.1016/j.jtct.2026.06.044.
Landmark-based evaluations of long-term outcomes after CD19 CAR T-cell therapy in large B-cell lymphoma. Gomez-Llobell M, Shouval R, Brown S, Goan-Accav N, Devlin S, Corona M, et al. Transplant Cell Ther. 2026;32(6):676.e1-676.e14. doi:10.1016/j.jtct.2026.02.058.
People
- MD: Technion, Israel Institute of Technology | Haifa, Israel
- PhD: Bar Ilan University | Ramat Gan, Israel
Members
- Alfonso Martín Escudero Foundation Fellowship
- Best Oral Presentation, Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH), 2024
- PhD awarded Cum Laude, University of Navarra, 2024
- NorthStar Van Norton Poche Hematology Fellowship – 2026
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
General Opportunities
For inquiries about graduate student rotations, postdoctoral fellowships, medical research fellowships, or technician positions, please contact [email protected].